Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML. (Q50523402)

14 March 2018

title

Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML. (English)

1 reference

14 March 2018

author name string

A W Elgie

1

1 reference

14 March 2018

J M Sargent

2

1 reference

14 March 2018

P Alton

3

1 reference

14 March 2018

G J Peters

4

1 reference

14 March 2018

P Noordhuis

5

1 reference

14 March 2018

C J Williamson

6

1 reference

14 March 2018

C G Taylor

7

1 reference

14 March 2018

publication date

1 April 1998

1 reference

14 March 2018

published in

Leukemia Research

1 reference

14 March 2018

volume

22

1 reference

14 March 2018

issue

4

1 reference

14 March 2018

page(s)

373-378

1 reference

14 March 2018

The action of arabinosylcytosine on synchronously growing populations of mammalian cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Multidrug resistance in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Effect of cell growth and cell differentiation on 1-beta-D-arabinofuranosylcytosine metabolism in myeloid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

The mechanism of protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Complexities of the protein kinase C pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

The cell membrane and cell signals: new targets for novel anticancer drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

A phase I study of intravenous bryostatin 1 in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Effects of bryostatin 1 and rGM-CSF on the metabolism of 1-beta-D-arabinofuranosylcytosine in human leukaemic myeloblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Modulation of metabolism and cytotoxicity of cytosine arabinoside with N-(phosphon)-acetyl-L-aspartate in human leukemic blast cells and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2898%2900011-3

7 January 2021

10.1016/S0145-2126(98)00011-3

Identifiers

DOI

1 reference

14 March 2018

release_olsdsbbdqbhtpj3cnomezd53wm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/olsdsbbdqbhtpj3cnomezd53wm

24 November 2022

mapped directly with Wikidata item

PubMed ID

9669842

1 reference

14 March 2018